2012
DOI: 10.5560/znc.2012.67c0275
|View full text |Cite
|
Sign up to set email alerts
|

Major Constituents and Cytotoxic Effects of Ajuga chamaecistus ssp. tomentella

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 0 publications
1
4
0
Order By: Relevance
“…4). This result is in agreement with the work of Sadati et al (2012) who documented the cytotoxic effect of Ajuga chamaecistus spp. tomentella on the T47D, Caco-2, and HT-29 cancer cell lines.…”
Section: Resultssupporting
confidence: 93%
“…4). This result is in agreement with the work of Sadati et al (2012) who documented the cytotoxic effect of Ajuga chamaecistus spp. tomentella on the T47D, Caco-2, and HT-29 cancer cell lines.…”
Section: Resultssupporting
confidence: 93%
“…extracts on B16.F10 murine melanoma and C26 colon carcinoma cells proliferation, 5 × 10 3 cancer cells/well were cultured in 96-well plates for 24 h. The range of concentrations for each extract was selected based on previous studies regarding in vitro cytotoxic activity of Ajuga sp. (Sadati et al, 2012) and the effect was measured in triplicate samples for the controls (cells incubated in medium alone) and for each concentration of the vegetal extracts. To screen for ethanol toxicity, cells were incubated with the same concentrations of the solvent as those used for the preparation of the ethanolic extracts.…”
Section: Methodsmentioning
confidence: 99%
“…Tomentella showed significant cytotoxic activity against colon carcinoma (HT-29), colorectal adenocarcinoma cells (Caco-2), breast ductal carcinoma (T47D), and Swiss mouse embryo fibroblasts (NIH-3T3), while the diethyl ether fraction was moderately cytotoxic against HT-29. 15 Furthermore, the antiproliferative activity of Ajugalide-B (ATMA) from A. taiwanensis was tested against hepatoma (HepG2), lung adenocarcinoma (A549), gastric carcinoma (AGS), and colon carcinoma (HT29). ATMA disrupted the focal adhesion complex and reduced phosphorylation by paxillin and focal adhesion kinase (FAK).…”
Section: Resultsmentioning
confidence: 99%